CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling
Clin Transl Med
.
2023 May;13(5):e1230.
doi: 10.1002/ctm2.1230.
Authors
Jianpeng Yu
1
,
Tianyu Shen
2
,
Yang Li
1
,
Tangxi Hao
1
,
Long Yang
3
,
Hanlin Li
1
,
Xuan-Mei Piao
4
,
Zheng Zhang
1
,
Shimiao Zhu
1
,
Changyi Quan
1
,
Wun-Jae Kim
4
,
Yang Zhao
1
,
Yuanjie Niu
1
,
Zhiqun Shang
1
Affiliations
1
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
2
School of Medical, Nankai University, Tianjin, China.
3
Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
4
Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea.
PMID:
37132132
PMCID:
PMC10154880
DOI:
10.1002/ctm2.1230
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Male
Prostate
Prostatic Neoplasms, Castration-Resistant*
Receptors, Androgen
Substances
Receptors, Androgen